Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
Not yet recruiting · NCT07552558 · Registry updated 2026-08-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC) | Head and Neck Neoplasms, Jaw Diseases, Mouth Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, bone disorder, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, jaw cancer, laryngeal disorder, laryngeal neoplasm, lip disorder, mouth disorder, musculoskeletal system disorder, neoplasm, otorhinolaryngologic disease, respiratory system disorder, respiratory tract neoplasm, skull neoplasm, squamous cell carcinoma, squamous cell neoplasm, tongue cancer, tongue disorder | Not yet recruiting | Phase 1 / Phase 2 | 2026-08-13 | NCT07552558 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bicara Therapeutics | 6 |
| Washington University School of Medicine | 475 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Washington University School of Medicine | St Louis | United States | 895 |